Venøs tromboembolisk sygdom ved COVID-19

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Maja Hellfritzsch
  • Thomas Kümler, Dansk Selskab for Trombose og Hæmostase, Herlev-Gentofte Hospital
  • ,
  • Anette Tarp Hansen
  • Marianne Tang, Dansk Selskab for Trombose og Hæmostase, Aarhus universitet, Århus
  • ,
  • Kasper Gymoese Berthelsen, Dansk Selskab for Trombose og Hæmostase, Aalborg Universitet
  • ,
  • Annette Dam Fialla, Dansk Selskab for Trombose og Hæmostase, Odense Universitetshospital
  • ,
  • Anita Sylvest Andersen, Dansk Selskab for Trombose og Hæmostase, Herlev-Gentofte Hospital
  • ,
  • Peter Kampmann, Dansk Selskab for Trombose og Hæmostase, Rigshospitalet
  • ,
  • Anne-Mette Hvas

The importance of venous thromboembolism (VTE) as a major complication in patients with severe corona virus disease 2019 (COVID-19) is becoming increasingly evident. In this review, we describe the proposed pathophysiology of the prothrombotic coagulation changes observed in patients with COVID-19. Further, based on a review of the currently available evidence on VTE prevalence in patients with COVID-19, we present and discuss the recommendations from the Danish Society of Thrombosis and Haemostasis on the use of thromboprophylaxis in patients with COVID-19.

Original languageDanish
Article numberV05200309
JournalUgeskrift for Læger
Volume182
Issue23
Number of pages10
ISSN0041-5782
Publication statusPublished - 2020

See relations at Aarhus University Citationformats

ID: 189445278